| Name | Title | Contact Details |
|---|
SIMMS AND MCIVOR is a Branchburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.
BroMenn Healthcare System is a Normal, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
himagine solutions inc. is a leading healthcare outsourcing solutions provider with the largest team of inpatient and outpatient coders in the U.S. Our professional HIM outsourcing services include basic staff augmentation as well as more strategic managed coding solutions including full department outsourcing through our Enterprise HIM offering to support more than 250 healthcare providers across the U.S. With our significant and growing base of HIM Subject Matter Experts we provide support for all of our offerings to ensure our client partners receive the most value from our services.
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing and commercializing a portfolio of large volume ready-to-use infusible pharmaceuticals. Our vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via our proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. Our infusion platform is intended to address some of the most pressing unmet needs in infusion today: cost, medication error, sterility, efficiency, and patient quality of life.